Cancellation of Patent Claims through Reexamination Insufficient to Mount Collateral Attack on Multimillion-Dollar Jury Verdict

Mar 2, 2020

Reading Time : 2 min

KAIST IP US LLC sued several companies for infringement of U.S. Patent No. 6,885,055 (the “’055 Patent”). At the completion of trial, the jury found that defendants had infringed at least one asserted claim of the ’055 Patent and that none of the asserted claims were invalid. Four months later, one of the defendants filed a request for ex parte reexamination of the ’055 Patent, which was granted by the U.S. Patent and Trademark Office (PTO). On reexamination, the PTO rejected the asserted claims. Given that KAIST had not yet exhausted its appeals of that decision, the PTO’s rejection had not yet been deemed final.

Defendants subsequently moved to stay the post-trial phase of the litigation pending completion of the reexamination. The court denied the motion on the basis that: (1) a stay would prejudice KAIST’s right to rely on a jury verdict it expended substantial resources to obtain; (2) the litigation had reached an advanced stage, in that the case had reached trial and both the jury and court had rendered decisions on the merits; and (3) any simplification to the case would be de minimis because only post-trial motions remained, which the court decided contemporaneously with the motion to stay.

In deciding against a stay, two tactical decisions by defendants were of particular importance to the court. First, defendants waited months until after the jury returned a verdict in favor of KAIST before filing the ex parte reexamination request. Second, defendants asserted unpatentability grounds in that request which were not presented to the jury. In the court’s view, filing a request for reexamination post-trial with new unpatentability grounds amounted to a “manipulat[ion] [of] an administrative process designed to streamline disputes to avoid the need for a jury trial.” The court also characterized defendants’ tactics as “a fourth bite at the apple” because defendants had failed on multiple occasions to obtain institution of inter partes review of the ’055 Patent during the pendency of the litigation. Finally, the court cautioned that the administrative remedies afforded by the Patent Act “should not be used to effect a collateral attack on the verdict of a jury empaneled pursuant to the Seventh Amendment or the judgments of an Article III court.” Indeed, the court noted that if the case were stayed and no final judgment issued, “the issuance of a final reexamination certificate would effect the destruction of this lawsuit.”

Practice Tip: A defendant will face significant obstacles justifying a stay during the post-trial phase of a patent infringement litigation where a jury has rendered a verdict in favor of the plaintiff. Such a stay may be even less palatable to a district court if the basis for seeking the stay is the cancellation of the asserted patent claims via ex parte reexamination on unpatentability grounds not presented to the jury. Thus, accused infringers seeking prompt resolution in a patent infringement dispute should exercise diligence in pursuing multiprong patent challenges.

Kaist IP US LLC v. Samsung Elecs. Co. et al., 2:16-cv-01314-JRG (E.D. Tex. Feb. 13, 2020) (Gilstrap, J.)

Share This Insight

Previous Entries

IP Newsflash

February 24, 2026

The Southern District of Florida recently dismissed a complaint without prejudice because the allegations used a form of “shotgun pleading.” The court explained that a shotgun pleading includes those where every count incorporates every preceding paragraph into each cause of action, and that dismissal of such pleadings was required under Eleventh Circuit precedent.

...

Read More

IP Newsflash

February 20, 2026

The Federal Circuit recently addressed whether the PTO must conduct notice‑and‑comment rulemaking before issuing instructions that guide how the Board should exercise discretion at the institution stage of IPRs. The court held that no such rulemaking is required. Instructions to the Board regarding its use of the Director’s delegated discretionary authority not to institute review are merely general statements of policy exempt from notice-and-comment rulemaking.  

...

Read More

IP Newsflash

February 18, 2026

The District Court for the District of Delaware recently invalidated claims directed to a panoramic objective lens for lack of enablement, holding the claims impermissibly recited a single element in means‑plus‑function form. Under § 112, ¶ 6, “[a]n element in a claim for a combination may be expressed as a means or step for performing a specified function….” By its plain terms, the statute permits means‑plus‑function claiming only in the context of a “combination.” In other words, a claim may not consist solely of a single means‑plus‑function element. Claims drafted as a single means are invalid for lack of enablement as a matter of law.

...

Read More

IP Newsflash

February 13, 2026

In an ANDA litigation, the District of Delaware recently denied the defendants’ motion to compel the production of correspondence between the plaintiffs’ testifying expert and a third-party analyst who had performed experiments and provided data used by the testifying expert. The court found that the scope of material sought by the motion was overbroad and disproportionate to the needs of the case.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.